Artelo Biosciences to Participate at the Benzinga Global Small Cap Conference on May 13, 2021 May 06, 2021 10:00am EDT
Artelo Biosciences Reports Second Quarter Fiscal 2021 Financial Results and Provides Business Update Apr 13, 2021 8:30am EDT
Artelo Biosciences Doses First Patient in CAReS Study with ART27.13 for the Treatment of Cancer-Related Anorexia and Weight Loss Apr 12, 2021 8:30am EDT
Artelo Biosciences Accepted into the Alderley Park Oncology Development Program for FABP5 Inhibitor Biomarker Development Mar 19, 2021 10:00am EDT
Artelo Biosciences, Inc. to Present at the Q1 Virtual Investor Summit on March 23rd Mar 11, 2021 7:10am EST
Artelo Biosciences Appoints Finance and Healthcare Industry Executive Tamara A. Seymour to Board of Directors Mar 09, 2021 8:30am EST
Artelo Biosciences to Present at the H.C. Wainwright Global Life Sciences Conference on March 9th Mar 02, 2021 8:30am EST
Artelo Biosciences Announces Positive Pre-Clinical Data Associated with Proprietary CBD Cocrystal Feb 17, 2021 8:30am EST
Artelo Biosciences Announces Appointment of Andrew Yates, Ph.D. as Senior Vice President and Chief Scientific Officer Feb 16, 2021 8:30am EST
Artelo Biosciences Receives $3.0 Million in Net Proceeds from Exercise of Warrants Feb 08, 2021 8:30am EST
